Research Library

Baker Institute health policy experts provide links to some of the sources they found helpful in understanding developments in the coronavirus outbreak.

Despite the Trump administration sentiment that the U.S. partner with Saudi Arabia in a joint oil alliance, such an approach is unlikely to be successful, write energy fellows Jim Krane and Mark Finley. Forbes blog: https://bit.ly/2WUa6rb

The populist government under President Andrés Manuel López Obrador has largely discounted the threat of COVID-19,  and the true extent of the outbreak Mexico may not yet be known. If conditions significantly change for the worse, the president faces not only a public health crisis but also the possible undoing of the country's populist experiment.

Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.

According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.

Despite internal changes in how scientists are nominated for the Nobel Prize, there is still a substantial gender bias in prize recipients. Concrete policy changes are needed to ensure more diversity is reflected in the world’s most visible and prestigious scientific honor, write experts Kenneth M. Evans, Kirstin R.W. Matthews and Daniel Moralí. Baker Institute blog: http://bit.ly/2MDRDbW

The massacre in El Paso is a symbol of complex social phenomena that we are experiencing today — and is not simply a matter of mental health, as Texas Gov. Greg Abbott and other politicians have stepped forward to suggest. Read more at the Baker Institute Blog.

"With the U.S. and Iran staggering toward war, it bears asking: How would U.S. interests be served by war with Iran?" writes fellow Jim Krane. Read his argument for why U.S. interests would be deeply undermined by any such war on the Baker Institute Blog.  This post originally appeared in the Forbes Blog on June 17, 2019.

According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.

While the U.S. still maintains the overall lead in Nobel prizes (with the exception of literature), the rate at which American scientists have been awarded the prize has declined since the late 1970s. Fellow Kirstin R.W. Matthews and postdoctoral fellow Kenneth M. Evans explore the state of scientific collaboration in the U.S. in this Baker Institute blog: https://bit.ly/2yiNhzF